Skip Nav Destination
Issues
1 October 2021
-
Cover Image
Cover Image
![issue cover]()
The cover shows a section of a breast biopsy from a patient with triple-negative breast cancer. Multiplex immunofluorescence shows high CD3+ T-cell infiltration (red) and low CD68+ immune cell infiltration (yellow) in the tumor-immune microenvironment. For details, see the article by Yam and colleagues on page 5365 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Perspectives in Regulatory Science and Policy
The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology
Julie A. Schneider; Yutao Gong; Kirsten B. Goldberg; Paul G. Kluetz; Marc R. Theoret; Laleh Amiri-Kordestani; Julia A. Beaver; Lola Fashoyin-Aje; Nicole J. Gormley; Adnan A. Jaigirdar; Steven J. Lemery; Pallavi S. Mishra-Kalyani; Gregory H. Reaman; Donna R. Rivera; Wendy S. Rubinstein; Harpreet Singh; Rajeshwari Sridhara; Richard Pazdur
Reviews
Perspectives
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Kenneth C. Anderson; Daniel Auclair; Stacey J. Adam; Amit Agarwal; Melissa Anderson; Hervé Avet-Loiseau; Mark Bustoros; Jessica Chapman; Dana E. Connors; Ajeeta Dash; Alessandra Di Bacco; Ling Du; Thierry Facon; Juan Flores-Montero; Francesca Gay; Irene M. Ghobrial; Nicole J. Gormley; Ira Gupta; Howard Higley; Jens Hillengass; Bindu Kanapuru; Dickran Kazandjian; Gary J. Kelloff; Ilan R. Kirsch; Brandon Kremer; Ola Landgren; Elizabeth Lightbody; Oliver C. Lomas; Sagar Lonial; María-Victoria Mateos; Rocio Montes de Oca; Lata Mukundan; Nikhil C. Munshi; Elizabeth K. O'Donnell; Alberto Orfao; Bruno Paiva; Reshma Patel; Trevor J. Pugh; Karthik Ramasamy; Jill Ray; Mikhail Roshal; Jeremy A. Ross; Caroline C. Sigman; Katie L. Thoren; Suzanne Trudel; Gary Ulaner; Nancy Valente; Brendan M. Weiss; Elena Zamagni; Shaji K. Kumar
Clinical Trials: Targeted Therapy
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A. Yap; Matthew G. Krebs; Sophie Postel-Vinay; Anthony El-Khouiery; Jean-Charles Soria; Juanita Lopez; Alienor Berges; S.Y. Amy Cheung; Itziar Irurzun-Arana; Andrew Goldwin; Brunella Felicetti; Gemma N. Jones; Alan Lau; Paul Frewer; Andrew J. Pierce; Glen Clack; Christine Stephens; Simon A. Smith; Emma Dean; Simon J. Hollingsworth
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study
Paolo A. Ascierto; Brigitte Dréno; James Larkin; Antoni Ribas; Gabriella Liszkay; Michele Maio; Mario Mandalà; Lev Demidov; Daniil Stroyakovskiy; Luc Thomas; Luis de la Cruz-Merino; Victoria Atkinson; Caroline Dutriaux; Claus Garbe; Jessie Hsu; Surai Jones; Haocheng Li; Edward McKenna; Athina Voulgari; Grant A. McArthur
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53
Mansoor N. Saleh; Manish R. Patel; Todd M. Bauer; Sanjay Goel; Gerald S. Falchook; Geoffrey I. Shapiro; Ki Y. Chung; Jeffrey R. Infante; Robert M. Conry; Guilherme Rabinowits; David S. Hong; Judy S. Wang; Ulrich Steidl; Loren D. Walensky; Gurudatta Naik; Vincent Guerlavais; Vojislav Vukovic; D. Allen Annis; Manuel Aivado; Funda Meric-Bernstam
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Debashis Sarker; Nancy A. Dawson; Ana M. Aparicio; Tanya B. Dorff; Allan J. Pantuck; Ulka N. Vaishampayan; Lynn Henson; Lakshmi Vasist; Sumita Roy-Ghanta; Michele Gorczyca; Whitney York; Gopinath Ganji; Jerry Tolson; Johann S. de Bono
RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non–Small Cell Lung Cancer
Kazuhiko Nakagawa; Ernest Nadal; Edward B. Garon; Makoto Nishio; Takashi Seto; Nobuyuki Yamamoto; Keunchil Park; Jin-Yuan Shih; Luis Paz-Ares; Bente Frimodt-Moller; Annamaria H. Zimmermann; Sameera Wijayawardana; Carla Visseren-Grul; Martin Reck; for the RELAY study investigators
Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma
Eun Joo Kang; Myung-Ju Ahn; Chan-Young Ock; Keun-Wook Lee; Jung Hye Kwon; Yaewon Yang; Yoon Hee Choi; Min Kyoung Kim; Jun Ho Ji; Tak Yun; Byung-Ho Nam; Sung-Bae Kim; Bhumsuk Keam
Clinical Trials: Immunotherapy
Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
Georgina V. Long; Caroline Robert; Marcus O. Butler; Felix Couture; Matteo S. Carlino; Steven O'Day; Victoria Atkinson; Jonathan S. Cebon; Michael P. Brown; Stéphane Dalle; Andrew G. Hill; Geoffrey T. Gibney; Steven McCune; Alexander M. Menzies; Cuizhen Niu; Nageatte Ibrahim; Blanca Homet Moreno; Adi Diab
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Samantha J. Seitter; Richard M. Sherry; James C. Yang; Paul F. Robbins; Mackenzie L. Shindorf; Amy R. Copeland; Christine T. McGowan; Monica Epstein; Thomas E. Shelton; Michelle M. Langhan; Zulmarie Franco; David N. Danforth; Donald E. White; Steven A. Rosenberg; Stephanie L. Goff
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer
Paula I. Gonzalez-Ericsson; Julia D. Wulfkhule; Rosa I. Gallagher; Xiaopeng Sun; Margaret L. Axelrod; Quanhu Sheng; Na Luo; Henry Gomez; Violeta Sanchez; Melinda Sanders; Lajos Pusztai; Emanuel Petricoin; Kim R.M. Blenman; Justin M. Balko; I-SPY2 Trial Team
Precision Medicine and Imaging
A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization
Xavier Sastre-Garau; Mamadou Diop; Fernando Martin; Gilles Dolivet; Frédéric Marchal; Claire Charra-Brunaud; Didier Peiffert; Léa Leufflen; Birama Dembélé; Jessica Demange; Priscillia Tosti; Jacques Thomas; Agnès Leroux; Jean-Louis Merlin; Halimatou Diop-Ndiaye; Jean-Marc Costa; Julia Salleron; Alexandre Harlé
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody
Laura Kist de Ruijter; Jahlisa S. Hooiveld-Noeken; Danique Giesen; Marjolijn N. Lub-de Hooge; Iris C. Kok; Adrienne H. Brouwers; Sjoerd G. Elias; Margaret T.L. Nguyen; Hong Lu; Jourik A. Gietema; Mathilde Jalving; Derk J.A. de Groot; Olga Vasiljeva; Elisabeth G.E. de Vries
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity
Ashwyn K. Sharma; Jorge de la Torre; Nikki S. IJzerman; Thomas L. Sutton; Beiqun Zhao; Tahsin M. Khan; Sudeep Banerjee; Christina Cui; Vi Nguyen; Maha Alkhuziem; Petur Snaebjornsson; Hester van Boven; Annemarie Bruining; Chih-Min Tang; Hyunho Yoon; Alexa De la Fuente; Shumei Kato; Hitendra Patel; Michael C. Heinrich; Christopher L. Corless; Santiago Horgan; Adam M. Burgoyne; Paul Fanta; Jill P. Mesirov; Andrew M. Blakely; Jeremy L. Davis; Skye C. Mayo; Winan J. van Houdt; Neeltje Steeghs; Jason K. Sicklick
Translational Cancer Mechanisms and Therapy
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Clinton Yam; Er-Yen Yen; Jeffrey T. Chang; Roland L. Bassett, Jr; Gheath Alatrash; Haven Garber; Lei Huo; Fei Yang; Anne V. Philips; Qing-Qing Ding; Bora Lim; Naoto T. Ueno; Kasthuri Kannan; Xiangjie Sun; Baohua Sun; Edwin Roger Parra Cuentas; William Fraser Symmans; Jason B. White; Elizabeth Ravenberg; Sahil Seth; Jennifer L. Guerriero; Gaiane M. Rauch; Senthil Damodaran; Jennifer K. Litton; Jennifer A. Wargo; Gabriel N. Hortobagyi; Andrew Futreal; Ignacio I. Wistuba; Ryan Sun; Stacy L. Moulder; Elizabeth A. Mittendorf
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression
Lijie Xing; Su Wang; Jiye Liu; Tengteng Yu; Hailin Chen; Kenneth Wen; Yuyin Li; Liang Lin; Phillip A. Hsieh; Shih-Feng Cho; Gang An; Lugui Qiu; Krista Kinneer; Nikhil Munshi; Kenneth C. Anderson; Yu-Tzu Tai
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4
Oscar Krijgsman; Kristel Kemper; Julia Boshuizen; David W. Vredevoogd; Elisa A. Rozeman; Sofia Ibanez Molero; Beaunelle de Bruijn; Paulien Cornelissen-Steijger; Aida Shahrabi; Martin Del Castillo Velasco-Herrera; Ji-Ying Song; Maarten A. Ligtenberg; Roelof J.C. Kluin; Thomas Kuilman; Petra Ross-Macdonald; John B.A.G. Haanen; David J. Adams; Christian U. Blank; Daniel S. Peeper
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma
Kit I. Tong; Sharon Yoon; Keren Isaev; Mehran Bakhtiari; Tracy Lackraj; Michael Y. He; Jesse Joynt; Anjali Silva; Maria C. Xu; Gilbert G. Privé; Housheng Hansen He; Rodger E. Tiedemann; Elizabeth A. Chavez; Lauren C. Chong; Merrill Boyle; David W. Scott; Christian Steidl; Robert Kridel
PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions
Rama Krishna Nimmakayala; Sanchita Rauth; Ramakanth Chirravuri Venkata; Saravanakumar Marimuthu; Palanisamy Nallasamy; Raghupathy Vengoji; Subodh M. Lele; Satyanarayana Rachagani; Kavita Mallya; Mokenge P. Malafa; Moorthy P. Ponnusamy; Surinder K. Batra
The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Neeraj Sharma; James B. Smadbeck; Nadine Abdallah; Cinthya Zepeda-Mendoza; Moritz Binder; Kathryn E. Pearce; Yan W. Asmann; Jess F. Peterson; Rhett P. Ketterling; Patricia T. Greipp; P. Leif Bergsagel; S. Vincent Rajkumar; Shaji K. Kumar; Linda B. Baughn
Advertisement
